Loss of Phenotype of Parvalbumin Interneurons in Rat Prefrontal Cortex Is Involved in Antidepressant- and Propsychotic-Like Behaviors Following Acute and Repeated Ketamine Administration
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Accumulating evidence has demonstrated that single subanesthetic dose of ketamine exerts rapid, robust, and lasting antidepressant-like effects. Nevertheless, repeated subanesthetic doses of ketamine produce psychosis-like effects with dysfunction of parvalbumin (PV) interneurons. We hypothesized that PV interneurons play an important role in the antidepressant-like actions of ketamine, and different changes in PV interneurons occur with the antidepressant-like and propsychotic-like effects of ketamine. To test this hypothesis, ketamine's antidepressant-like effects were evaluated by the forced swimming test. Ketamine-induced stereotyped behaviors and hyperactivity actions and the function of PV interneurons were also assessed. We demonstrated that an acute dose of 10 mg/kg ketamine induced significant antidepressant-like effects and reduced the levels of PV and the gamma-aminobutyric acid (GABA)-producing enzyme GAD67 in the rat prefrontal cortex. Moreover, inhibition of ketamine-induced loss of PV by apocynin blocked these antidepressant-like effects. Repeated administration of 30 mg/kg ketamine elicited stereotyped behaviors and hyperactivity actions as well as a longer duration of PV and GAD67 loss, higher brain glutamate levels, and lower brain GABA levels than acute single dose of ketamine. Our results reveal that the loss of phenotype of PV interneurons in the prefrontal cortex contributes to the antidepressant-like actions and is also involved in the propsychotic-like…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a single dose of ketamine (10 mg/kg i.p.), which elicits rapid antidepressant-like effects in the forced swim test, coincided with a reduction in GAD67, PV, and GABA levels and an increase in glutamate levels 30 minutes post-administration in the PFC (Zhou et al., 2015).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Zhou et al., 2015
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Self-citationParvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
Self-citationZarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585
Signaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537
Animal Models of Depression: Molecular Perspectives
Krishnan, V., & Nestler, E. J. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2010_108 · Cited by 528
Lodge, D. J., Behrens, M. M., & Grace, A. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5419-08.2009 · Cited by 488
Zhang, Z. J., & Reynolds, G. P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00188-8 · Cited by 460
Garcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454
Lorrain, D. S., Baccei, C. S., Bristow, L. J., Anderson, J. J., & Varney, M. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00652-8 · Cited by 432
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond
Krystal, J. H., Sanacora, G., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.026 · Cited by 406
Koike, H., Iijima, M., & Chaki, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.035 · Cited by 346
Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia
Becker, A., Peters, B., Schroeder, H., Mann, T., Huether, G., & Grecksch, G. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00080-0 · Cited by 339
Ibrahim, L., DiazGranados, N., Franco-Chaves, J., Brutsche, N., Henter, I. D., Kronstein, P., Moaddel, R., Wainer, I., Luckenbaugh, D. A., Manji, H. K., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.338 · Cited by 309
Thase, M. E., Haight, B. R., Richard, N., Rockett, C. B., Mitton, M., Modell, J. G., VanMeter, S., Harriett, A. E., & Wang, Y. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0803 · Cited by 304
Wilson, F. A., O'Scalaidhe, S. P., & Goldman-Rakic, P. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4009 · Cited by 303
Beurel, E., Song, L., & Jope, R. S. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.47 · Cited by 288
Sex differences in the antidepressant-like effects of ketamine
Carrier, N., & Kabbaj, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.009 · Cited by 251
Cornwell, B. R., Salvadore, G., Furey, M., Marquardt, C. A., Brutsche, N. E., Grillon, C., & Zarate, C. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.029 · Cited by 200
Keilhoff, G., Becker, A., Grecksch, G., Wolf, G., & Bernstein, H.-G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.039 · Cited by 199
The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine
Monteggia, L. M., Gideons, E., & Kavalali, E. T. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.006 · Cited by 198
The acute effects of NMDA antagonism: From the rodent to the human brain
Gunduz-Bruce, H. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.07.006 · Cited by 182
Are We Getting Closer to Valid Translational Models for Major Depression?
Berton, O., Hahn, C.-G., & Thase, M. E. (2012) · Science · doi:10.1126/science.1222940 · Cited by 148
Povysheva, N. V., Gonzalez-Burgos, G., Zaitsev, A. V., Kröner, S., Barrionuevo, G., Lewis, D. A., & Krimer, L. S. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj002 · Cited by 146
Becker, A., & Grecksch, G. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.06.019 · Cited by 143
Quibell, R., Prommer, E., Mihalyo, M., Twycross, R., & Wilcock, A. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.01.001 · Cited by 143
Razoux, F., Garcia, R., & Léna, I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301057 · Cited by 135
Dwyer, J. M., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.011 · Cited by 132
Zhang, Y., Behrens, M. M., & Lisman, J. E. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00079.2008 · Cited by 107
Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine
de Oliveira, L., Fraga, D. B., Luca, R. D. D., Canever, L., Ghedim, F. V., Matos, M. P. P., STRECK, E. L., Quevedo, J., & Zugno, A. I. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9234-1 · Cited by 95
Xi, D., Zhang, W., Wang, H.-X., Stradtman, G. G., & Gao, W.-J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900042x · Cited by 83
Chaviaras, S., Mak, P., Ralph, D., Krishnan, L., & Broadbear, J. H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1815-x · Cited by 80
Nicotine Improves Working Memory Span Capacity in Rats Following Sub-Chronic Ketamine Exposure
Rushforth, S. L., Steckler, T., & Shoaib, M. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.224 · Cited by 76
Romano‐Silva, M. A., Ribeiro-Santos, R., Ribeiro, A. M., Gomez, M. V., Diniz, C. R., Cordeiro, M. N., & Brammer, M. J. (1993) · Biochemical Journal · doi:10.1042/bj2960313 · Cited by 71
Zuo, D., Wu, Y., Yao, W.-X., Cao, Y., Wu, C., & Tanaka, M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.010 · Cited by 66
Berdel, B., & Moryś, J. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00024-1 · Cited by 66
Amphetamine induces hydroxyl radical formation in the striatum of rats
Huang, N., Wan, F.-J., Tseng, C., & Tung, C. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00924-7 · Cited by 58
Choi, S., Roh, D., Yoon, S. Y., Kang, S.-Y., Moon, J.-Y., Kwon, S. G., Choi, H., Han, H. J., Beitz, A. J., Oh, S. B., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.05.004 · Cited by 57
Pinheiro, A. C. D. N., da Silva, A. J., Prado, M. A. M., Cordeiro, M. N., Richardson, M., Batista, M. C., de Castro, C. J., Massensini, A. R., Guatimosim, C., Romano‐Silva, M. A., et al. (2009) · Hippocampus · doi:10.1002/hipo.20580 · Cited by 43
Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin
Turner, C. P., DeBenedetto, D., Ware, E., Stowe, R. C., Lee, A. J., Swanson, J. M., Walburg, C., Lambert, A., Lyle, M. A., Desai, P., et al. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-2059-z · Cited by 36
Tomiya, M., Fukushima, T., Kawai, J., Aoyama, C., Mitsuhashi, S., Santa, T., Imai, K., & Toyo'oka, T. (2006) · Biomedical chromotography · doi:10.1002/bmc.677 · Cited by 32
Zadrożna, M., Nowak, B., Łasoń-Tyburkiewicz, M., Wolak, M., Sowa-Kućma, M., Papp, M., Ossowska, G., Pilc, A., & Nowak, G. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70718-6 · Cited by 27
Mitochondrial Regulation of NADPH Oxidase in Hindlimb Unweighting Rat Cerebral Arteries
Zhang, R., Ran, H.-H., Peng, L., Xu, F., Sun, J.-F., Zhang, L.-N., Fan, Y.-Y., Peng, L., & Cui, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095916 · Cited by 22
Aoyama, T., Hida, K., Kuroda, S., Seki, T., Yano, S., Shichinohe, H., & Iwasaki, Y. (2008) · Neurologia medico-chirurgica · doi:10.2176/nmc.48.539 · Cited by 22
Vosoughin, M., Mohammadi, S., & Dabbagh, A. (2012) · Journal of Anesthesia · doi:10.1007/s00540-012-1399-1 · Cited by 20
Noda, Y., Mouri, A., Waki, Y., & Nabeshima, T. (2009) · PubMed · Cited by 6
Research works printed but not linked: 3
- Beurel E, Song L, Jope RS (2011) Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 16:1068–1070 · DOI · Paper page
- Razoux F, Garcia R, Léna I (2007) Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Neuropsychopharmacology 32:719–727 · DOI
- Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA (2003) Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697–706 · DOI · Paper page
Cited by
Page, C. E., & Coutellier, L. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.024 · Cited by 213
Pham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186
“In contrast, EAAT3 is a neuronal transporter and also abundant in the cerebral cortex.”
BackgroundInfluentialMechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Liu, W., Wang, J., Xie, Z.-M., Xu, N., Zhang, G.-F., Jia, M., Zhou, Z., Hashimoto, K., & Yang, J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4128-2 · Cited by 169
“A previous study of our laboratory has proved that the reduction of parvalbumin and gamma-aminobutyric acid (GABA)-producing enzyme GAD67 underlies the excessive release of glutamate (Zhou et al. 2015).”
Self-citationPre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies
Kaar, S. J., Angelescu, I., Marques, T. R., & Howes, O. D. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02080-2 · Cited by 170
Metadata
- Authors
- Zhou, Z., Zhang, G., Li, X., Liu, X., Wang, N., Qiu, L., Liu, W., Zuo, Z., & Yang, J.
- Affiliations
- Nanjing General Hospital of Nanjing Military Command (CN)
- University of Virginia (US)
- Corresponding author
- Zuo, ZhiYi
- Yang, JianJun
- Venue
- Molecular Neurobiology
- Published
- 2014-06-28
- Volume
- 51
- Issue
- 2
- Pages
- 808-819
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2044993165
- Cited by
- 64
- References
- 55
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 9 · 2021: 4 · 2020: 12 · 2019: 7 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 2
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, parvalbumin interneurons, prefrontal cortex, antidepressant-like effects, stereotypy, hyperactivity, GAD67, glutamate signaling, apocynin, forced swim test
- MeSH terms
- Animals, Antidepressive Agents, Drug Administration Schedule, Interneurons, Ketamine, Male, Parvalbumins, Phenotype, Psychoses, Substance-Induced, Rats, Wistar, Prefrontal Cortex, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.